Ursodoxicoltaurine: all 25 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity IndexNot yet recruitingNCT07517276Phase 2
- Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and BevacizumabRecruitingNCT07100392Phase 2
- Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective StudyNot yet recruitingNCT07064668Phase 2
- Effect of Oral Supplements for Influenza Vaccine ResponseNot yet recruitingNCT06827873Not applicable
- Targeting Endoplasmic Reticulum Stress in Human HypertensionRecruitingNCT06025630Phase 1/2
- A Trial of Bile Acid Supplementation in Patients With Multiple SclerosisCompletedNCT03423121Phase 1/2Results posted
- Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 DiabetesCompletedNCT02218619Phase 2Results posted
- Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin ResistanceCompletedNCT01877551Not applicableResults posted
- Doxycycline and TUDCA in Patients With Transthyretin Amyloid CardiomyopathyCompletedNCT01855360Phase 1/2Results posted
- Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral SclerosisCompletedNCT00877604Phase 2Results posted
- Effect of Endoplasmic Reticulum Stress on Metabolic FunctionCompletedNCT00771901Not applicableResults posted
- Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.WithdrawnNCT07457632Phase 2
- Open Label Extension of TUDCA-ALS StudyStatus unknownNCT05753852Phase 3
- The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.Status unknownNCT04727320Early Phase 1
- Trial of Tauroursodeoxycholic Acid (TUDCA) in AsthmaTerminatedNCT03878654Phase 1
- Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALSActive, not recruitingNCT03800524Phase 3
- A Study of Doxycycline and Tauroursodeoxycholic Acid (Doxy/TUDCA) Plus Standard Supportive Therapy Versus Standard Supportive Therapy Alone in Cardiac Amyloidosis Caused by TransthyretinCompletedNCT03481972Phase 3
- Effects of TUDCA on Endothelial Function in Type 2 DMTerminatedNCT03462940Not applicable
- Effects of Dietary Supplement Tauroursodeoxycholic Acid on Vascular FunctionCompletedNCT03331432Not applicable
- The Discovery of the Double Sphincter in GallbladderStatus unknownNCT01998451Phase 4
- Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary CirrhosisCompletedNCT01857284Phase 3
- Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBCCompletedNCT01829698Phase 3
- Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin AmyloidosisCompletedNCT01171859Phase 2
- Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic FibrosisCompletedNCT00004441Not applicable
- Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in InfantsCompletedNCT00004410Not applicable